Small Cap https://www.benzinga.com/views/taxonomy/term/46411 en 'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines https://www.benzinga.com/m-a/21/05/21024467/spacs-attack-recap-looking-back-at-5-spac-deals-rumors-and-top-headlines <p>Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs. Here is a look back at the week in SPACs for deals, rumors and headline news all covered on Benzinga&rsquo;s &ldquo;<a href="https://www.youtube.com/playlist?list=PL4k0fH8EgI3Z9twaah9Sz_PQQ7VC19X_Y">SPACs Attack</a>.&rdquo;</p> <h2><strong>SPAC Deals</strong></h2> <p>Navitas Semiconductor <a href="https://www.prnewswire.com/news-releases/navitas-semiconductor-the-industry-leader-in-gallium-nitride-gan-power-ics-to-go-public-at-an-enterprise-value-of-1-04-billion-via-live-oak-ii-spac-business-combination-301286331.html">announced </a>a SPAC deal with <strong>Live Oak Acquisition Corp II </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lokb#NYSE">LOKB</a>). The deal values the company at $1.04 billion. Navitas has proprietary GaNFast, a next generation semiconductor technology that the company says can deliver up to three times faster charging in half the size and weight compared to legacy silicon chips. Over 18 million GaNFast power ICs have shipped to key customers including Dell, Lenovo, LG, Amazon and Belkin. Markets for the GaN include mobile, consumer enterprise, renewables and electric vehicles.</p> <p>Science 37, a developer of the decentralized clinical trial operating system, <a href="https://www.businesswire.com/news/home/20210507005149/en/Science-37-to-Become-Publicly-Listed-via-Merger-with-LifeSci-Acquisition-II-Corp.-Powering-the-Clinical-Trial-Operating-System-of-the-Future">announced </a>a SPAC merger with <strong>LifeSci Acquisition II Corp </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lsaq#NASDAQ">LSAQ</a>). The company provides customers with a platform to &ldquo;empower clinical research while optimizing the experience and outcomes for patients and researchers.&rdquo; The company has completed over 95 clinical trials involving more than 366,000 patients. Science 37 believes it can speed up patient enrollment, improve patient retention and reach a more representative population. The company works with pharmaceutical companies, biotech companies and academic and governmental institutions.</p> <p>ESS Tech <a href="https://www.businesswire.com/news/home/20210507005241/en/">announced </a>a SPAC deal with <strong>ACON S2 Acquisition Corp</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stwo#NASDAQ">STWO</a>). ESS Tech is an energy storage company that has a low-cost storage battery that could help support renewables and stabilize the electrical grid. ESS is seeking to develop low-cost energy storage systems unlike traditional lithium-ion batteries. ESS uses abundant elements like iron, salt and water, which are more cost effective and environmentally safe.</p> <p>Jasper Therapeutics, a biotech company focused on hematopoietic stem cell transplants, is <a href="https://www.businesswire.com/news/home/20210506005725/en/Jasper-Therapeutics-and-Amplitude-Healthcare-Acquisition-Corporation-Announce-Merger-to-Create-a-Publicly-Listed-Leading-Biotechnology-Company-in-Hematopoietic-Stem-Cell-Transplantation">going public</a> with <strong>Amplitude Healthcare Acquisition Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amhc#NASDAQ">AMHC</a>). The deal is expected to help Jasper advance their JSP191 through trials in patients with AML/MDS. Jasper is targeting life threatening diseases like blood cancers, sickle cell diseases and immunodeficiencies.</p> <p>Roivant Sciences is going public with<strong> Montes Archimedes Acquisition Corp</strong> ...</p><p><a href=https://www.benzinga.com/m-a/21/05/21024467/spacs-attack-recap-looking-back-at-5-spac-deals-rumors-and-top-headlines alt=&#039;SPACs Attack&#039; Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines>Full story available on Benzinga.com</a></p> ABUS ACTC AMHC ARVL Bloomberg CFAC Chamath Palihapitiya DKNG EBAY Equinox FTOC GENI GTPB IACB IMVT IPOF LEV LOKB LSAQ M&A MAAC News NFTs non-fungible token online sports betting Payoneer PLBY PTON SIOX SPAC SPACs SPACs Attack STWO TTCF UBER Small Cap IPOs Trading Ideas STWO EBAY US2786421030 ARVL ACTC US00752K1051 LSAQ UBER ABUS MAAC LEV LOKB GENI GTPB PTON IACB AMHC IMVT DKNG FTOC IPOF TTCF PLBY CFAC SIOX News M&A Small Cap IPOs Trading Ideas Benzinga Sat, 08 May 2021 20:16:41 +0000 Chris Katje 21024467 at https://www.benzinga.com Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against CytoDyn Inc. https://www.benzinga.com/pressreleases/21/05/n21024139/deadline-alert-kessler-topaz-meltzer-check-llp-alerts-investors-of-lead-plaintiff-deadline-in-secu <p xmlns="http://www.w3.org/1999/xhtml">RADNOR, Pa., <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 8, 2021</span> /PRNewswire/ -- The law firm of Kessler Topaz Meltzer &amp; Check, LLP reminds investors that securities fraud class action lawsuit has been filed against CytoDyn Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CYDY#OTC" rel="nofollow">CYDY</a>) (&#34;CytoDyn&#34;) on behalf of those who purchased or acquired CytoDyn common stock <b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">between <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 27, 2020</span> and <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 9, 2021</span></i></b>, inclusive (the &#34;Class Period&#34;).</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1219383/KTMC_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1219383/KTMC_Logo.jpg" title="KTMC Logo (PRNewsfoto/Kessler Topaz Meltzer &amp; Check, LLP)" alt="KTMC Logo (PRNewsfoto/Kessler Topaz Meltzer &amp; Check, LLP)" /><br /> </a> </p> </div> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">Deadline Reminder: Investors who purchased or acquired CytoDyn common stock</i></b> <b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">during the Class Period may, <u xmlns="http://www.w3.org/1999/xhtml">no later than <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 17, 2021</span></u>, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer &amp; Check, LLP: James Maro, Esq. (484) 270-1453 or <span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Adrienne Bell, Esq.</span> (484) 270-1435; toll free at (844) 887-9500; via e-mail at</i></b> <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="mailto:info@ktmc.com" rel="nofollow" rel="nofollow">info@ktmc.com</a>; <b xmlns="http://www.w3.org/1999/xhtml">or</b> <b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">click </i></b><a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3156360-1&amp;h=4028245041&amp;u=https%3A%2F%2Fwww.ktmc.com%2Fcytodyn-class-action-lawsuit%3Futm_source%3DPR%26utm_medium%3Dlink%26utm_campaign%3Dcytodyn&amp;a=https%3A%2F%2Fwww.ktmc.com%2Fcytodyn-class-action-lawsuit%3Futm_source%3DPR%26utm_medium%3Dlink%26utm_campaign%3Dcytodyn" rel="nofollow" rel="nofollow">https://www.ktmc.com/cytodyn-class-action-lawsuit?utm_source=PR&amp;utm_medium=link&amp;utm_campaign=cytodyn</a>  </p> <p xmlns="http://www.w3.org/1999/xhtml">CytoDyn is a biotechnology company that has focused on the development and commercialization of a drug named &#34;Leronlimab&#34; which has long been promoted as a potential therapy for HIV ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/n21024139/deadline-alert-kessler-topaz-meltzer-check-llp-alerts-investors-of-lead-plaintiff-deadline-in-secu alt=Deadline Alert: Kessler Topaz Meltzer &amp; Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against CytoDyn Inc.>Full story available on Benzinga.com</a></p> CYDY Small Cap Press Releases Sat, 08 May 2021 16:47:00 +0000 PRNewswire 21024139 at https://www.benzinga.com The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More https://www.benzinga.com/news/21/05/21023794/the-past-weeks-notable-insider-buys-amphenol-aldeyra-werewolf-therapeutics-and-more <ul> <li><em>Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.</em></li> <li><em>Once again, some insiders have taken advantage of initial public offerings.</em></li> <li><em>A couple of chief executive officers were among the insiders buying shares this past week.</em></li> </ul> <p>Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason &mdash; they believe the stock price will rise and they want to profit from it. So <a href="https://www.benzinga.com/news/insider-trades" target="_blank">insider buying</a> can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets or the markets are near all-time highs.</p> <p>Note that, with the earnings reporting season still underway, many insiders are prohibited from buying or selling shares. Here are some of the most noteworthy insider purchases that were reported in the past week.</p> <p>A number of 10% owners of and directors at <strong>Werewolf Therapeutics Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/howl#NASDAQ">HOWL</a>) bought into its initial public offer last week. The more than 4.84 million shares they bought for $16.00 apiece totaled over $77.98 million altogether. Shares of this cancer-focused biopharma company closed the week&#39;s trading at $14.25 apiece.</p> <p>The purchase of 1.20 million <strong>Aldeyra Therapeutics Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aldx#NASDAQ">ALDX</a>) shares by a beneficial owner came before last week&#39;s first-quarter report. At the public offering price of $12.50 per share, those transactions totaled $15.00 million. ...</p><p><a href=https://www.benzinga.com/news/21/05/21023794/the-past-weeks-notable-insider-buys-amphenol-aldeyra-werewolf-therapeutics-and-more alt=The Past Week&#039;s Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More>Full story available on Benzinga.com</a></p> AAT Aldeyra Therapeutics ALDX American Assets Trust ANAB AnaptysBio APAM APH Artisan Partners Asset Management Cyclerion Therapeutics CYCN eli lilly HOWL INTC Intel KDP Keurig Dr Pepper LLY News NOVA Penny Stocks Rockwell Automation ROK Sunnova Energy TRUP Trupanion VACC Vaccitech Werewolf Therapeutics Weyerhaeuser WY Small Cap Insider Trades INTC US4581401001 NOVA APH US0320951017 LLY US5324571083 ROK US7739031091 WY US9621661043 AAT US0240131047 APAM ALDX TRUP ANAB KDP CYCN VACC HOWL News Penny Stocks Small Cap Insider Trades Benzinga Sat, 08 May 2021 16:10:14 +0000 Nelson Hem 21023794 at https://www.benzinga.com Delic Holdings Inc. Confirms No Material Undisclosed Information and Comments on Recent Promotional Activities https://www.benzinga.com/pressreleases/21/05/n21023381/delic-holdings-inc-confirms-no-material-undisclosed-information-and-comments-on-recent-promotional <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">VANCOUVER, BC</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 8, 2021</span> /CNW/ - Delic Holdings Inc. (&#34;<b xmlns="http://www.w3.org/1999/xhtml">DELIC</b>&#34; or the &#34;<b xmlns="http://www.w3.org/1999/xhtml">Company</b>&#34;) (CSE:<a class="ticker" href="https://www.benzinga.com/stock/DELC#CSE" rel="nofollow">DELC</a>) (OTCQB: DELCF), a psychedelic wellness-focused company, announces that the Company is not aware of any material undisclosed information and wishes to make the following statements regarding recent sponsored news and marketing activities concerning its shares of common shares traded on the OTCQB market.</p> <p xmlns="http://www.w3.org/1999/xhtml">On <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 6, 2021</span>, OTC Markets Group (&#34;OTC Markets&#34;) sent the Company a copy of a newsletter article published by Financial News Now.com on <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 16, 2021</span> (the &#34;Article&#34;) and email distribution between <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 6-7</span> and requested comment from the Company. The article and email discuss recent mental health research, current events in the psychedelics industry, a description of the Company&#39;s business plan, board of directors, state of the current market, and matters relating to investment in the Company. The website is owned by IDR Marketing, Inc. (&#34;IDR&#34;), which was retained by the Company to assist with financial marketing efforts in order to increase investor awareness within <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">North America</span>. This was previously disclosed by news release by the Company on <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">February 5, 2021</span>. The Company engaged IDR to provide financial marketing, public relations services, social media support and/or other related services. The company notes that trading activity remained consistent during this time. </p> <p xmlns="http://www.w3.org/1999/xhtml">IDR&#39;s engagement is to factually tell the Company&#39;s story in an accretive and transparent manner. Statements made in the promotional materials are not materially false and/or misleading. The factual information provided in the promotional material, which was extracted from the Company&#39;s public disclosure, website and press releases, is accurate, however, any opinions expressed by the author are his alone as the Company had no right of edit or control over those opinions.</p> <p xmlns="http://www.w3.org/1999/xhtml">Since its public listing on the Canadian Securities Exchange on <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">November 18, 2020</span>, the Company has further engaged the following additional parties to ‎provide investor relations, public relations services, marketing or other related services including Investor Direct Media, Octagon Media, Equity Guru, Streetwise Reports, Triple Bull Consulting, and Capital Analytica.</p> <p xmlns="http://www.w3.org/1999/xhtml">After reasonable inquiry‎, management is not aware of any ‎directors, officers or any third-party service providers that have sold ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/n21023381/delic-holdings-inc-confirms-no-material-undisclosed-information-and-comments-on-recent-promotional alt=Delic Holdings Inc. Confirms No Material Undisclosed Information and Comments on Recent Promotional Activities>Full story available on Benzinga.com</a></p> CSE:DELC DELCF Small Cap Press Releases Sat, 08 May 2021 09:57:00 +0000 PRNewswire 21023381 at https://www.benzinga.com Delic Holdings Inc. Confirms No Material Undisclosed Information and Comments on Recent Promotional Activities https://www.benzinga.com/pressreleases/21/05/n21023380/delic-holdings-inc-confirms-no-material-undisclosed-information-and-comments-on-recent-promotional <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">VANCOUVER, BC</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 8, 2021</span> /PRNewswire/ - Delic Holdings Inc. (&#34;<b xmlns="http://www.w3.org/1999/xhtml">DELIC</b>&#34; or the &#34;<b xmlns="http://www.w3.org/1999/xhtml">Company</b>&#34;) (CSE:<a class="ticker" href="https://www.benzinga.com/stock/DELC#CSE" rel="nofollow">DELC</a>) (OTCQB: DELCF), a psychedelic wellness-focused company, announces that the Company is not aware of any material undisclosed information and wishes to make the following statements regarding recent sponsored news and marketing activities concerning its shares of common shares traded on the OTCQB market.</p> <p xmlns="http://www.w3.org/1999/xhtml">On <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 6, 2021</span>, OTC Markets Group (&#34;OTC Markets&#34;) sent the Company a copy of a newsletter article published by Financial News Now.com on <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 16, 2021</span> (the &#34;Article&#34;) and email distribution between <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 6-7</span> and requested comment from the Company. The article and email discuss recent mental health research, current events in the psychedelics industry, a description of the Company&#39;s business plan, board of directors, state of the current market, and matters relating to investment in the Company. The website is owned by IDR Marketing, Inc. (&#34;IDR&#34;), which was retained by the Company to assist with financial marketing efforts in order to increase investor awareness within <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">North America</span>. This was previously disclosed by news release by the Company on <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">February 5, 2021</span>. The Company engaged IDR to provide financial marketing, public relations services, social media support and/or other related services. The company notes that trading activity remained consistent during this time. </p> <p xmlns="http://www.w3.org/1999/xhtml">IDR&#39;s engagement is to factually tell the Company&#39;s story in an accretive and transparent manner. Statements made in the promotional materials are not materially false and/or misleading. The factual information provided in the promotional material, which was extracted from the Company&#39;s public disclosure, website and press releases, is accurate, however, any opinions expressed by the author are his alone as the Company had no right of edit or control over those opinions.</p> <p xmlns="http://www.w3.org/1999/xhtml">Since its public listing on the Canadian Securities Exchange on <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">November 18, 2020</span>, the Company has further engaged the following additional parties to ‎provide investor relations, public relations services, marketing or other related services including Investor Direct Media, Octagon Media, Equity Guru, Streetwise Reports, Triple Bull Consulting, and Capital Analytica.</p> <p xmlns="http://www.w3.org/1999/xhtml">After reasonable inquiry‎, management is not aware of any ‎directors, officers or ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/n21023380/delic-holdings-inc-confirms-no-material-undisclosed-information-and-comments-on-recent-promotional alt=Delic Holdings Inc. Confirms No Material Undisclosed Information and Comments on Recent Promotional Activities>Full story available on Benzinga.com</a></p> CSE:DELC DELCF Small Cap Press Releases Sat, 08 May 2021 09:57:00 +0000 PRNewswire 21023380 at https://www.benzinga.com CBOA Financial, Inc. Reports Consolidated Earnings of $543,000 in 1Q 2021 https://www.benzinga.com/pressreleases/21/05/n21023064/cboa-financial-inc-reports-consolidated-earnings-of-543-000-in-1q-2021 <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">TUCSON, Ariz.</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 7, 2021</span> /PRNewswire/ -- CBOA Financial, Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBOF#OTC" rel="nofollow">CBOF</a>) (the &#34;Company&#34;), parent company of Commerce Bank of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Arizona</span> (the &#34;Bank&#34; or &#34;CBAZ&#34;), announced that consolidated after tax net income for quarter ending <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2021</span> increased 46% to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$543,000</span>, from <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$371,000</span> year-over-year.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1505924/Commerce_Bank_of_Arizona_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1505924/Commerce_Bank_of_Arizona_Logo.jpg" title="Commerce Bank of Arizona (PRNewsfoto/Commerce Bank of Arizona)" alt="Commerce Bank of Arizona (PRNewsfoto/Commerce Bank of Arizona)" /><br /> </a> </p> </div> <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Chris Webster</span>, Bank President and Chief Executive Officer commented, &#34;Our year over year performance validates our current operating strategy; successful pursuit of quality loan opportunities combined with disciplined loan pricing. We also continue to steadily decrease the bank&#39;s nonperforming assets which is critical in the current environment. On top of this strong performance, our lending staff processed another <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$27 million</span> of Paycheck Protection Program (PPP) loans, providing much needed support to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Arizona</span> businesses.&#34;</p> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">First Quarter 2021 Highlights</b></p> <ul xmlns="http://www.w3.org/1999/xhtml" type="disc"> <li xmlns="http://www.w3.org/1999/xhtml">Traditional (non-PPP) Loan Growth was <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$18 million</span>, or 10% for the quarter </li> <li xmlns="http://www.w3.org/1999/xhtml">Net Interest Margin increased 10 basis points for the quarter </li> <li xmlns="http://www.w3.org/1999/xhtml">Nonperforming assets decreased 16% for the quarter</li> </ul> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">Operational Highlights</b></p> <p xmlns="http://www.w3.org/1999/xhtml">Interest income was aided by recognized fee income of PPP loans that bolstered earnings by <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$550,000</span>.  Further contributing to the growth in net interest income was a <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$41,000</span> decline in interest expense despite the <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$1 million</span> increase in total deposits during the quarter.</p> <p xmlns="http://www.w3.org/1999/xhtml">The Bank continues to make progress on its legacy classified assets. Year-over-year, non-performing assets which include loans and OREO are down 59% from <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$6.3 million</span> or 2.4% of assets to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$2.6 million</span> or 0.77% of assets.</p> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">Balance Sheet</b></p> <p xmlns="http://www.w3.org/1999/xhtml">Total assets increased by 3% to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$365.2 million</span> during the quarter ended <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2021</span> and increased 49.8% compared to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$243.8 million</span> a year ago. Total asset growth from <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 2020</span> to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 2021</span> consisted of PPP loans funding CBAZ deposit accounts totaling <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$60 million</span> and organic net deposit growth of roughly <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$24 million</span>.</p> <p xmlns="http://www.w3.org/1999/xhtml">Traditional gross loans increased <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$18 million</span> since fourth quarter 2020 ending the first quarter 2021 at <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$198 million</span>. Total gross loans increased by 8.3% to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$260 million</span> in the quarter and increased 49% compared to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$174 million</span> a year ago. Total deposits increased by 0.3% to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$305 million</span> during the quarter and increased 43% compared to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$213 million</span> a year ago.</p> <p xmlns="http://www.w3.org/1999/xhtml">The allowance for loan losses totaled <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$2.97 million</span> at <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2021</span>, or 1.5% of &#34;traditional&#34; non-PPP loans, compared to 1.64% in the previous quarter, and was 1.14% for the quarter with the PPP loans included. </p> <p xmlns="http://www.w3.org/1999/xhtml">Shareholders&#39; equity remained at <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$25 million</span> at <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2021</span>, from the preceding quarter. At <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2021</span>, book value and tangible book value were <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$2.81</span> per share compared to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$2.81</span> per share at <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">December 31, 2020</span> and <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$2.71</span> per share a year ago. Excluding the PPP loans, the Bank&#39;s third quarter 2020 Tier 1 Leverage ratio would have been 9.8%, just above 9.2% for fourth quarter 2020 and 11.1% as of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2020</span>. Growth in total assets associated with the PPP loans was the primary driver of a decline in the Bank&#39;s Tier 1 Leverage ratio. </p> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">Capital Management</b></p> <p xmlns="http://www.w3.org/1999/xhtml">Capital ratios exceeded regulatory guidelines for a well-capitalized institution under Basel III and Dodd Frank Wall Street Reform requirements at <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2021</span>. Capital ratios are presented below.</p> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">About the Company</b></p> <p xmlns="http://www.w3.org/1999/xhtml">Commerce Bank of Arizona, established in 2002 in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Tucson, Arizona</span>, is a full-service community bank that caters to small-to mid-sized businesses and real estate professionals. CBAZ offers commercial clients with a variety of services ranging from U.S. Small Business Administration (SBA) financing solutions, construction loans, and commercial real estate loans. CBOA Financial, Inc is a single-bank holding company and parent of the Bank. The Company is traded over-the-counter as CBOF. For additional information, visit: <b xmlns="http://www.w3.org/1999/xhtml"><a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3156839-1&amp;h=1817482625&amp;u=http%3A%2F%2Fwww.commercebankaz.com.%2F&amp;a=www.commercebankaz.com." rel="nofollow" rel="nofollow">www.commercebankaz.com.</a></b></p> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">Forward-looking Statements</b></p> <p xmlns="http://www.w3.org/1999/xhtml">This press release may include forward-looking statements about CBOA Financial, Inc. or Commerce Bank of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Arizona</span>. These statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the following factors: competition, fluctuations in interest rates, dependency on key individuals, loan defaults, geographical concentration, litigation and changes in federal laws, regulations and interpretations thereof. All forward-looking statements included in this press release are based on information available at the time of the release, and CBOA Financial, Inc. and Commerce Bank of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Arizona</span> assume no obligation to update any forward-looking statement. </p> <div xmlns="http://www.w3.org/1999/xhtml"> <table xmlns="http://www.w3.org/1999/xhtml" cellspacing="0" cellpadding="0" border="0" class="prnbcc"> <tr xmlns="http://www.w3.org/1999/xhtml"> <td ...</tr></table></div><p><a href=https://www.benzinga.com/pressreleases/21/05/n21023064/cboa-financial-inc-reports-consolidated-earnings-of-543-000-in-1q-2021 alt=CBOA Financial, Inc. Reports Consolidated Earnings of $543,000 in 1Q 2021>Full story available on Benzinga.com</a></p> Banking/Financial Services CBOF Earnings Small Cap Press Releases Sat, 08 May 2021 04:51:00 +0000 PRNewswire 21023064 at https://www.benzinga.com SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Perpetual Federal Savings Bank - PFOH https://www.benzinga.com/pressreleases/21/05/n21022707/shareholder-alert-monteverde-associates-pc-announces-an-investigation-of-perpetual-federal-savings <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 7, 2021</span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3155657-1&amp;h=1369224747&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fjmonteverde&amp;a=Juan+Monteverde" rel="nofollow" rel="nofollow"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Juan Monteverde</span></a>, founder and managing partner at <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3155657-1&amp;h=951203959&amp;u=http%3A%2F%2Fwww.monteverdelaw.com%2F&amp;a=Monteverde+%26+Associates+PC" rel="nofollow" rel="nofollow">Monteverde &amp; Associates PC</a>, a national securities firm rated <b xmlns="http://www.w3.org/1999/xhtml">Top 50 </b>in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">New York City</span>, is investigating<b xmlns="http://www.w3.org/1999/xhtml"> Perpetual Federal Savings Bank (&#34;PFOH&#34; or the &#34;Company&#34;)</b> (PFOH) relating to its proposed acquisition by Farmers &amp; Merchants Bancorp, Inc. (FMAO). Under the terms of the agreement, PFOH shareholders will receive either <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$41.20</span> in cash or 1.7766 shares of FMAO stock per share they own.</p> <p xmlns="http://www.w3.org/1999/xhtml">The investigation focuses on whether Perpetual Federal Savings Bank and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.</p> <p xmlns="http://www.w3.org/1999/xhtml" class="prntac"><b xmlns="http://www.w3.org/1999/xhtml">Click here for more information</b>: <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3155657-1&amp;h=2976034638&amp;u=https%3A%2F%2Fwww.monteverdelaw.com%2Fcase%2Fperpetual-federal-savings-bank&amp;a=https%3A%2F%2Fwww.monteverdelaw.com%2Fcase%2Fperpetual-federal-savings-bank" rel="nofollow" rel="nofollow">https://www.monteverdelaw.com/case/perpetual-federal-savings-bank</a><b xmlns="http://www.w3.org/1999/xhtml">. It is free and ...</b></p><p><a href=https://www.benzinga.com/pressreleases/21/05/n21022707/shareholder-alert-monteverde-associates-pc-announces-an-investigation-of-perpetual-federal-savings alt=SHAREHOLDER ALERT: Monteverde &amp; Associates PC Announces an Investigation of Perpetual Federal Savings Bank - PFOH>Full story available on Benzinga.com</a></p> Banking/Financial Services PFOH Small Cap Press Releases Sat, 08 May 2021 01:00:00 +0000 PRNewswire 21022707 at https://www.benzinga.com Renaissance Announces Conversion of Outstanding Convertible Debentures https://www.benzinga.com/pressreleases/21/05/n21022688/renaissance-announces-conversion-of-outstanding-convertible-debentures <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">VANCOUVER, BC</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 7, 2021</span> /CNW/ - Renaissance Oil Corp. (&#34;Renaissance&#34; or the &#34;Company&#34;) (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/ROE#TSXV" rel="nofollow">ROE</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/RNSFF#OTCQB" rel="nofollow">RNSFF</a>) is pleased to announce that it has received notices of conversion from each holder of the Company&#39;s outstanding convertible debentures (the &#34;Debentures&#34;) previously issued on <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 6, 2019</span> (the &#34;Conversion&#34;). This will result in the conversion of all outstanding Debentures having an aggregate principal amount of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">C$5,000,000</span> into 20,000,000 common shares of the Company (the &#34;Common Shares&#34;) at a conversion price of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">C$0.25</span> per Common Share. </p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1505974/Renaissance_Oil_Corp__Renaissance_Announces_Conversion_of_Outsta.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1505974/Renaissance_Oil_Corp__Renaissance_Announces_Conversion_of_Outsta.jpg" title="Renaissance Oil Corp. Logo (CNW Group/Renaissance Oil Corp.)" alt="Renaissance Oil Corp. Logo (CNW Group/Renaissance Oil Corp.)" /><br /> </a> </p> </div> <p xmlns="http://www.w3.org/1999/xhtml">Pursuant to the terms of the Debentures, interest on the principal amount of the Debentures has accrued daily at a rate of 10% per annum. In connection with the Conversion, the Company ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/n21022688/renaissance-announces-conversion-of-outstanding-convertible-debentures alt=Renaissance Announces Conversion of Outstanding Convertible Debentures>Full story available on Benzinga.com</a></p> Oil RNSFF TSXV:ROE Utilities Commodities Small Cap Press Releases Sat, 08 May 2021 00:50:00 +0000 PRNewswire 21022688 at https://www.benzinga.com Journey Energy Inc. Returns to Profitability in the First Quarter of 2021 https://www.benzinga.com/pressreleases/21/05/n21022448/journey-energy-inc-returns-to-profitability-in-the-first-quarter-of-2021 <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">CALGARY, AB</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 7, 2021</span> /CNW/ - Journey Energy Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/JOY#TSX" rel="nofollow">JOY</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/JRNGF#OTCQX" rel="nofollow">JRNGF</a>) (&#34;<b xmlns="http://www.w3.org/1999/xhtml">Journey</b>&#34; or the &#34;<b xmlns="http://www.w3.org/1999/xhtml">Company</b>&#34;) announces its financial results for the first quarter of 2021.  The complete set of financial statements and management discussion and analysis for the periods ended <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2021</span> and 2020 are posted on <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3156847-1&amp;h=1515371022&amp;u=http%3A%2F%2Fwww.sedar.com%2F&amp;a=www.sedar.com" rel="nofollow" rel="nofollow">www.sedar.com</a> and on the Company&#39;s website <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3156847-1&amp;h=553403954&amp;u=http%3A%2F%2Fwww.journeyenergy.ca%2F&amp;a=www.journeyenergy.ca" rel="nofollow" rel="nofollow">www.journeyenergy.ca</a>.</p> <p xmlns="http://www.w3.org/1999/xhtml"><u xmlns="http://www.w3.org/1999/xhtml">Highlights for the first quarter are as follows:</u></p> <ul xmlns="http://www.w3.org/1999/xhtml" type="disc"> <li xmlns="http://www.w3.org/1999/xhtml">Produced 7,577 boe/d with 54% coming from natural gas production; 38% from crude oil and 8% from NGL&#39;s. 100% of Journey&#39;s production is currently unhedged.<br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Realized adjusted funds flow of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$8.7 million</span> or <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$0.20</span> per basic share. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Reduced net debt by 35% to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$83.7 million</span> from <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$128.4 million</span> at the end of the first quarter of 2020. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Continued work on decommissioning non-producing sites. To date Journey has been allocated <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$3.4 million</span> under the Site Rehabilitation Program.<br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Produced 5,854 megawatts of electricity at Journey&#39;s new electricity generation facility in Countess, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Alberta</span> at an average price of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$130</span>/MW.</li> </ul> <p xmlns="http://www.w3.org/1999/xhtml"> </p> <div xmlns="http://www.w3.org/1999/xhtml"> <table xmlns="http://www.w3.org/1999/xhtml" cellspacing="0" cellpadding="0" border="0" class="prntblns"> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" colspan="3" class="prngen3"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">Three months ended<br xmlns="http://www.w3.org/1999/xhtml" /></b></span><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">March 31,</b></span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prnsbtb0 prnrbrb0 prnvab prnsbtb0 prnpl6 prnsblb0 prnpr6"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">Financial ($000&#39;s except per share </i></b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" rowspan="2" class="prngen5"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"> </p> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">2021</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" rowspan="2" class="prngen5"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"> </p> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">2020</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" rowspan="2" class="prngen3"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">%<br xmlns="http://www.w3.org/1999/xhtml" /></span><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">change</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen6"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">amounts)</i></b></span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen7"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Production revenue</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">23,575</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">18,336</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">29</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Net earnings (loss)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">1,699</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(65,441)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(103)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Per basic share</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">0.04</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(1.52)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(103)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Per diluted share</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">0.04</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(1.52)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(103)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Adjusted Funds flow</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">8,712</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(205)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(4,350)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Per basic share</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">0.20</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(0.01)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(2,100)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Per diluted share</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">0.18</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(0.01)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(1,900)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Cash flow from operations</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">4,295</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">1,382</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">211</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Per basic share</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">0.10</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">0.03</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">233</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Per diluted share</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">0.09</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">0.03</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">200</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Net capital expenditures</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">465</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">3,276</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(86)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Net debt</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">83,729</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">128,435</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(35)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen11"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">Share Capital (000&#39;s)</i></b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen11"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Basic, weighted average</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">44,001</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">44,001</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">-</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Basic, end of period</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">44,001</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">44,001</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">-</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Fully diluted</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">52,504</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">48,174</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">9</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen11"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">Daily Sales Volumes</i></b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen11"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Natural gas (Mcf/d)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Conventional</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">19,429</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">22,624</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(14)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen6"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Coal bed methane</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">5,083</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">6,198</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen14"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(18)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen6"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Total natural gas volumes</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">24,512</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">28,822</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen14"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(15)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen7"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Crude oil (Bbl/d)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Light/medium</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">2,160</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">3,071</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(30)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen6"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Heavy</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">710</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">737</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen14"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(4)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen6"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnml10"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Total crude oil volumes</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">2,870</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">3,808</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen14"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(25)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen6"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Natural gas liquids (Bbl/d)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">622</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">713</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen14"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(13)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prnsbt1 prnsbr1 prnvab prnsbbd prnpl6 prnsbl1 prnpr6"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Barrels of oil equivalent (boe/d)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen16"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">7,577</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen16"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">9,325</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prnsbt1 prnsbr1 prnvab prnsbbd prntar prnpl6 prnsbl1 prnpr6"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(19)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen11"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">Average Prices (excluding hedging)</i></b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen11"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Natural gas ($/mcf)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">3.00</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">1.23</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen12"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">144</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Crude Oil ($/bbl)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">57.37</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">40.03</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">43</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Natural gas liquids ($/bbl)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">38.16</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">19.00</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">101</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Barrels of oil equivalent ($/boe)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">34.57</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">21.61</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">60</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen6"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">Netbacks</i></b><b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml"> ($/boe)</i></b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen13"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen7"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Realized prices (excl. hedging)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">34.57</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">21.61</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen8"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">60</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Royalties</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">(3.71)</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(3.18)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">17</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Operating expenses</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">(14.46)</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen10"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(13.86)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">4</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Transportation expenses</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen14"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">(0.44)</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen14"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(0.53)</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen14"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">(17)</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen9"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">Operating netback</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen16"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span"><b xmlns="http://www.w3.org/1999/xhtml">15.96</b></span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen16"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">4.04</span></p> </td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen16"> <p xmlns="http://www.w3.org/1999/xhtml" class="prnews_p"><span xmlns="http://www.w3.org/1999/xhtml" class="prnews_span">295</span></p> </td> </tr> <tr xmlns="http://www.w3.org/1999/xhtml"> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> <td xmlns="http://www.w3.org/1999/xhtml" class="prngen2"><br xmlns="http://www.w3.org/1999/xhtml" /></td> </tr> </table> </div> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">OPERATIONS</b></p> <p xmlns="http://www.w3.org/1999/xhtml">Journey achieved sales volumes of 7,577 boe/d (46% crude oil and NGL&#39;s) in the first quarter of 2021, representing a 19% reduction from 9,325 (48% crude oil and NGL&#39;s) produced in the first quarter of 2020. The decrease in production is due to natural declines and a lack of capital for both drilling and optimization projects.  The declines are reflective of the higher initial decline rates from wells drilled in 2019, and are not reflective of Journey&#39;s current base decline rate. Journey&#39;s current annual decline rate is estimated to be 14% and is expected to be moderated by optimization projects returning shut in wells to production.   </p> <p xmlns="http://www.w3.org/1999/xhtml">In mid-March of 2020 the COVID-19 pandemic was causing systematic shutdowns of global economies, and world oil prices experienced a severe decline.  WTI oil prices declined below USD <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$20</span>/bbl making several of Journey&#39;s oil properties uneconomic to operate.  Consequently, Journey took the prudent and immediate action to shut-in approximately 1,500 boe/d (73% crude oil and NGL&#39;s) of its production effective the first week of April.  Journey restarted the majority of shut-in production early in the third quarter of 2020. </p> <p xmlns="http://www.w3.org/1999/xhtml">Journey did not drill or complete any wells in 2020.  Capital expenditures for 2020 were limited to maintenance capital where deemed necessary, as well as the completion and commissioning of our power generation project. The power project commenced operations in late September.  One key feature of the power project as designed, is the ease in which the project can be expanded to over 6 megawatts from the current maximum capacity of 4.0 megawatts, with the addition of one additional power generation unit.  Over the past six months Journey has seen a dramatic increase in pricing for both natural gas and electricity, and remains well positioned to take full advantage of these increases in 2021. </p> <p xmlns="http://www.w3.org/1999/xhtml">In 2020 Journey was focused on repositioning its capital structure to provide maximum liquidity over the medium term.  This focus will continue into 2021 with Journey planning to use available cash flow to satisfy its short term obligations. Journey plans on returning to the field in late 2021 or early 2022 and this should increase both production and oil weighting to pre pandemic levels over time. Journey&#39;s low decline and predictable asset base will provide the Company with a stable platform for this growth in 2022.  Journey will continue to monitor broader market forces and adjust its capital plans on an ongoing basis. </p> <p xmlns="http://www.w3.org/1999/xhtml">Journey has a development drilling program ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/n21022448/journey-energy-inc-returns-to-profitability-in-the-first-quarter-of-2021 alt=Journey Energy Inc. Returns to Profitability in the First Quarter of 2021>Full story available on Benzinga.com</a></p> Earnings JRNGF Oil TSX:JOY Utilities Commodities Small Cap Press Releases Fri, 07 May 2021 23:15:00 +0000 PRNewswire 21022448 at https://www.benzinga.com Willow Biosciences Reports First Quarter 2021 Results, an Operational Update and the Addition of a New Board Member https://www.benzinga.com/pressreleases/21/05/n21022357/willow-biosciences-reports-first-quarter-2021-results-an-operational-update-and-the-addition-of-a- <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">VANCOUVER, BC</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 7, 2021</span> /CNW/ - Willow Biosciences Inc. (&#34;<b xmlns="http://www.w3.org/1999/xhtml">Willow</b>&#34; or the &#34;<b xmlns="http://www.w3.org/1999/xhtml">Company</b>&#34;) (TSX: WLLW) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CANSF#OTCQX" rel="nofollow">CANSF</a>) has released its financial and operating results for the three months ended <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2021</span>, reporting significant advancement in its operations and strong liquidity.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1505916/Willow_Biosciences_Inc__Willow_Biosciences_Reports_First_Quarter.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1505916/Willow_Biosciences_Inc__Willow_Biosciences_Reports_First_Quarter.jpg" title="Willow Biosciences Inc. (CNW Group/Willow Biosciences Inc.)" alt="Willow Biosciences Inc. (CNW Group/Willow Biosciences Inc.)" /><br /> </a> </p> </div> <p xmlns="http://www.w3.org/1999/xhtml">&#34;The first quarter represented another significant move forward for us, as we completed our first commercial scale fermentation run and strengthened our balance sheet for success,&#34; said <span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Trevor Peters</span>, Willow&#39;s President and Chief Executive Officer. &#34;We are entering the next phase for the Company, which is creating new markets for our ultra-pure, sustainably made, cannabinoids, and our world class team has allowed us to be at the forefront of the industry. As the industry continues to move towards increased regulation from a health and safety perspective, there is a need now more than ever for Willow&#39;s consistent and safe manufacturing process. We are excited to continue to deliver value for all Willow stakeholders.&#34;</p> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">Highlights for the Quarter</b></p> <ul xmlns="http://www.w3.org/1999/xhtml" type="disc"> <li xmlns="http://www.w3.org/1999/xhtml">On <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">January 13, 2021</span>, Willow announced the appointment of Dr. <span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Mathias Schuetz</span> to Vice President, Plant Science. Dr. Schuetz was previously Vice President, Research &amp; Development.  The Company also announced the promotion of Dr. <span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Trish Choudhary</span> to Vice President, Research &amp; Development to lead the Company&#39;s yeast strain engineering efforts. Dr. Choudhary has been with Willow since <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">April 2019</span> in the role of Senior Director, Strain Engineering. </li> <li xmlns="http://www.w3.org/1999/xhtml">On <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">January 19, 2021</span>, the Company announced that it had advanced its work on its proprietary yeast strain producing Tetrahydrocannabinol (&#34;<b xmlns="http://www.w3.org/1999/xhtml">THC</b>&#34;) and plans to commercially launch in the Canadian market. </li> <li xmlns="http://www.w3.org/1999/xhtml">On <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">February 19, 2021</span>, Willow announced the closing of a bought deal public offering of common shares of the Company (&#34;<b xmlns="http://www.w3.org/1999/xhtml">Common Shares</b>&#34;) for gross proceeds of approximately <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$28.75 million</span> (the &#34;<b xmlns="http://www.w3.org/1999/xhtml">Bought Deal</b>&#34;).  Under the terms of the Bought Deal, the Company issued 17.4 million Common Shares at a price of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$1.65</span> per Common Share. </li> <li xmlns="http://www.w3.org/1999/xhtml">On <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 3, 2021</span>, Willow announced that the accelerated expiry of approximately 9.3 million Common Share purchase warrants resulted in cash proceeds of approximately <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$7.9 million</span>. </li> <li xmlns="http://www.w3.org/1999/xhtml">On <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2021</span>, the Company announced that it had completed the first commercial scale fermentation run of its first cannabinoid for market, cannabigerol (&#34;<b xmlns="http://www.w3.org/1999/xhtml">CBG</b>&#34;). </li> <li xmlns="http://www.w3.org/1999/xhtml">Willow ended the quarter with strong liquidity, including approximately <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$46.4 million</span> of cash on hand as at <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">March 31, 2021</span>.</li> </ul> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">Operational Update</b></p> <p xmlns="http://www.w3.org/1999/xhtml">During the first quarter of 2021, Willow continued to optimize its yeast strain, fermentation process, and downstream purification process for production of CBG, and it successfully scaled the process to commercial scale fermenters at its first selected contract manufacturing organization (&#34;<b xmlns="http://www.w3.org/1999/xhtml">CMO</b>&#34;) facilities based in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Europe</span>. Ongoing optimization of the scaled process to further improve production yields will continue in 2021 along with qualification of additional CMOs as required.  </p> <p xmlns="http://www.w3.org/1999/xhtml">The Company continued to work with Signum Biosciences, Inc. to evaluate the safety and activity of its CBG as an ingredient for cosmetics. The Company anticipates completion of the lab-based and clinic-based safety work in the second quarter of 2021. The Company also engaged a regulatory consulting group ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/n21022357/willow-biosciences-reports-first-quarter-2021-results-an-operational-update-and-the-addition-of-a- alt=Willow Biosciences Reports First Quarter 2021 Results, an Operational Update and the Addition of a New Board Member>Full story available on Benzinga.com</a></p> CANSF Earnings TSX:WLLW Small Cap Press Releases Fri, 07 May 2021 22:55:00 +0000 PRNewswire 21022357 at https://www.benzinga.com The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of ChemoCentryx, Inc. (CCXI) Investors https://www.benzinga.com/pressreleases/21/05/b21022308/the-law-offices-of-frank-r-cruz-announces-the-filing-of-a-securities-class-action-on-behalf-of-che <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.frankcruzlaw.com%2F&amp;esheet=52426121&amp;newsitemid=20210507005636&amp;lan=en-US&amp;anchor=The+Law+Offices+of+Frank+R.+Cruz&amp;index=1&amp;md5=2853b1b32281f772bfc17752c4191341" shape="rect" rel="nofollow">The Law Offices of Frank R. Cruz</a> announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ccxi#NASDAQ" rel="nofollow">CCXI</a>) common stock between <b xmlns="http://www.w3.org/1999/xhtml">November 26, 2019 and May 3, 2021</b>, inclusive (the "Class Period"). ChemoCentryx investors have until <b xmlns="http://www.w3.org/1999/xhtml">July 6, 2021</b> to file a lead plaintiff motion. </p> <p xmlns="http://www.w3.org/1999/xhtml"> If you are a shareholder who suffered a loss, click <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.frankcruzlaw.com%2Fcases%2Fchemocentryx-inc%2F&amp;esheet=52426121&amp;newsitemid=20210507005636&amp;lan=en-US&amp;anchor=here&amp;index=3&amp;md5=955fe9c30ab0a60fc13c2c6b99fd94a3" shape="rect" rel="nofollow">here</a> to participate. </p> <p xmlns="http://www.w3.org/1999/xhtml"> ChemoCentryx is a biopharmaceutical company. Its lead drug candidate is avacopan, which is developed as a potential treatment for ANCA-associated vasculitis ("AAV"). </p> <p xmlns="http://www.w3.org/1999/xhtml"> On July 9, 2020, ChemoCentryx announced that it had filed its New Drug Application ("NDA") for avacopan to the U.S. Food and Drug Administration ("FDA") for the treatment of AAV. </p> <p xmlns="http://www.w3.org/1999/xhtml"> On May 4, 2021, the FDA released a "Briefing Document" concerning the Company&#039;s NDA for avacopan, stating that "[c]omplexities of the study design, as detailed in the briefing document, raise questions about the interpretability of the data to define a clinically ...</p><p><a href=https://www.benzinga.com/pressreleases/21/05/b21022308/the-law-offices-of-frank-r-cruz-announces-the-filing-of-a-securities-class-action-on-behalf-of-che alt=The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of ChemoCentryx, Inc. (CCXI) Investors>Full story available on Benzinga.com</a></p> CCXI Small Cap Press Releases Fri, 07 May 2021 22:48:00 +0000 Business Wire 21022308 at https://www.benzinga.com The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more <p>This was an eventful week for the cannabis industry.</p> <p>On Monday, <strong>Tilray, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>) and <strong>Aphria, Inc. </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apha#NASDAQ">APHA</a>) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with <strong>Irwin Simon,</strong> CEO of the new combined company.</p> <p>Check out the video below:</p> <p><iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" frameborder="0" height="315" src="https://www.youtube.com/embed/S1nh5QRepd4" width="560"></iframe></p> <p>Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.</p> <p><strong>Jazz Pharmaceuticals</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jazz#NASDAQ">JAZZ</a>) finalized its acquisition of <strong>GW Pharmaceuticals plc. </strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gwph#NASDAQ">GWPH</a>), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion&nbsp;net of GW Pharma&#39;s cash.</p> <p>Meanwhile, <strong>Ascend Wellness Holdings</strong> (CSE: AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.</p> <p><strong><em>Benzinga Cannabis&rsquo; content is now available in Spanish on </em></strong><a href="https://elplanteo.com/"><strong><em>El Planteo</em></strong></a><strong><em>. </em></strong></p> <p>After two weeks of consolidating below resistance at the $1&nbsp;level, shares of Reddit favorite <strong>Sundial Growers Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sndl#NASDAQ">SNDL</a>) have resumed their downtrend.</p> <p><strong>Credit Suisse Group AG</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cs#NYSE">CS</a>)&nbsp;reportedly stopped handling transactions in shares of cannabis companies with U.S. operations and plans to refrain from holding cannabis stocks on behalf of its clients.</p> <p>The Swiss-based lender, which declined to give a statement, was among a handful of banks willing to buy and sell marijuana-related stocks and hold the shares as a custodian for clients in the United States. While it&#39;s not yet clear what impact this decision will have, Reuters reported&nbsp;the move has affected the sale of marijuana stocks in recent weeks.</p> <p>In fact, all major ETFs were down. Over the five trading days of this week:</p> <ul> <li>The <strong>ETFMG Alternative Harvest ETF </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mj#NYSE">MJ</a>): lost 0.2%.</li> <li>The <strong>AdvisorShares Pure Cannabis ETF </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/yolo#NYSE">YOLO</a>): tumbled 1.8%.</li> <li>The <strong>AdvisorShares Pure US Cannabis ETF </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msos#NYSE">MSOS</a>): shed 0.2% of its value.</li> <li>The <strong>Cannabis ETF </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/thcx#NYSE">THCX</a>): dropped 3.4%.</li> <li>The <strong>Amplify Seymour Cannabis ETF </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cnbs#NYSE">CNBS</a>): was down 3.5%.</li> <li>The <strong>SPDR S&amp;P 500 ETF Trust </strong>(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spy#NYSE">SPY</a>) closed the week up 1.21%.</li> </ul> <h2>Policy, Science And Data</h2> <p>In New York, people gathered to celebrate cannabis legalization.</p> <p>&ldquo;Last weekend&#39;s annual New York City cannabis parade brought out a who&#39;s who in politicians jockeying for position to be the one who was <em>always</em> supportive of legalizing cannabis. Ah-hem. Water under the bridge shall we say,&rdquo; commented Debra Borchardt, CEO of <a href="https://www.greenmarketreport.com/">Green Market Report</a>. &ldquo;With adult use cannabis sales likely to be legal by next year&#39;s parade, the people who attended were clearly in a celebratory mood. The New York market is expected to be the largest in the country and there were many small businesses working the crowd. There should be a Tinder app for social equity applicants to hook up with investors as there was a lot of talk about social equity applicants, but most have no money or very little.&rdquo;</p> <p>In Colorado<strong> </strong>Gov. Jared Polis signed a bill that would expand&nbsp;access to medical cannabis for school children in need by removing obstacles to its administration.</p> <h2>Financings And M&amp;A</h2> <p><strong>Jushi Holdings Inc. </strong>(CSE: JUSH) (OTC: <a class="ticker" href="https://www.benzinga.com/stock/jushf#OTC">JUSHF</a>) finalized its purchase of a 93,000 sq. ft. facility operated by its subsidiary, <strong>Dalitso LLC</strong>, for around $22 million. The deal also includes nearly nine acres of surrounding land in Prince William County, Virginia.</p> <p><strong>High Tide Inc.</strong> (TSXV: HITI) (OTCQB: <a class="ticker" href="https://www.benzinga.com/stock/hitif#OTCQB">HITIF</a>) (FRA: 2LY) will acquire 80% of <strong>Fab Nutrition, LLC</strong>. (operating as FABCBD) for $20.64 million in stock and cash.</p> <p><strong>MassRoots, Inc.</strong> (OTC: <a class="ticker" href="https://www.benzinga.com/stock/msrt#OTC">MSRT</a>) is looking to acquire <strong>Empire Services, Inc</strong>. for $14 million in a primarily stock-based transaction.</p> <p><strong>Trulieve Cannabis Corp</strong>. (CSE: TRUL) (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/tcnnf#OTCQX">TCNNF</a>) purchased West Virginia-based<strong> Mountaineer Holding LLC</strong> for $6 million.</p> <p><strong>Cansortium Inc.</strong> (CSE: TIUM), (OTCQB: <a class="ticker" href="https://www.benzinga.com/stock/cntmf#OTCQB">CNTMF</a>), doing business under the Fluent brand, exercised its right to regain up to the maximum of $5 million of convertible promissory notes, originally issued in the amount of $10 million in 2019.</p> <p><strong>Green Thumb Industries Inc.</strong> (CSE: GTII) (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/gtbif#OTCQX">GTBIF</a>) will reach the Virginia market via its acquisition of <strong>Dharma Pharmaceuticals LLC. </strong></p> <h2>Earnings Reports</h2> <p><strong>Kiaro Holdings Corp.</strong> (TSXV: KO) reported record revenues of CA$17.1 million in 2021, representing a year-over-year increase of 230%. ...</p><p><a href=https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more alt=The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&amp;A, And More>Full story available on Benzinga.com</a></p> ACRGF APDN APHA Aurora aurora news AVCNF Canadian cannabis news Cannabis Cannabis ETF cannabis legalization news cannabis news cannabis news California cannabis news today cannabis stock Cannabis Stock Index cannabis stock news cannabis stocks CBD CNBS CNBX CNTMF CS Debra Borchardt Green Market Report GTBIF GWPH HITIF IIPR invest in marijuana JAZZ JUSHF LOWLF marijuana Marijuana ETF Marijuana Index Marijuana Money marijuana news marijuana stocks marijuana stocks 2019 MJ MMNFF MSOS MSRT News NORML ORVRD Penny Stocks PLNHF POSAF pot news Pot Stocks SMG SNDL SPY TCNNF THCX TLRY YOLO ZLDAF Small Cap Markets SPY US78462F1030 TCNNF JAZZ US4721471070 YOLO CS US2254011081 APHA SMG US8101861065 ACRGF APDN US03815U1025 CNTMF GWPH HITIF CNBX POSAF MSRT CNBS MJ SNDL IIPR JUSHF THCX AVCNF ZLDAF MSOS MMNFF LOWLF TLRY US88688T1007 ORVRD GTBIF PLNHF News Penny Stocks Cannabis Small Cap Markets Benzinga Fri, 07 May 2021 21:36:03 +0000 Javier Hasse 21021448 at https://www.benzinga.com Braxia Scientific Introduces "Braxia Health" a Growing Network of Clinics Leading Novel Psychedelic Research and Treatments for Mental Disorders https://www.benzinga.com/pressreleases/21/05/n21021727/braxia-scientific-introduces-braxia-health-a-growing-network-of-clinics-leading-novel-psychedelic- <ul xmlns="http://www.w3.org/1999/xhtml" type="disc"> <li xmlns="http://www.w3.org/1999/xhtml">Braxia Scientific enters a new chapter as it commences trading under its new ticker &#34;CSE: BRAX&#34; and rebrands its growing network of leading clinics to Braxia Health, which includes the Canadian Rapid Treatment Centre of Excellence established in 2018. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Only clinic in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Canada</span> previously involved in a randomized controlled pivotal trial for regulatory approval purposes of psilocybin for the treatment of adults with depression. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Led by Dr. <span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Roger McIntyre</span>, the top-rated expert in <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3152666-2&amp;h=4010939238&amp;u=https%3A%2F%2Fexpertscape.com%2Fgo%2Fdepression&amp;a=depression" rel="nofollow" rel="nofollow">depression</a> since 2010 as rated by Expertscape, Braxia Health has the largest clinical research footprint for ketamine and psychedelic-based research in the world, providing the fastest route to development of its IP capable formulations and IP capable delivery methods. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">First community-based centre in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Canada</span> to specialize in rapid-acting treatments for patients with treatment resistant major depressive disorder and bipolar disorder. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">First <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Ontario</span> based centre licenced by the College of Physicians and Surgeons Ontario under the Out of Hospital Premises Program to perform ketamine IV treatments for depression. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Over 3,000 intravenous Ketamine Infusions and 345 intranasal and sublingual Ketamine treatments administered to date in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Canada</span>. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Focused on robust expansion throughout <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Canada</span>, the U.S. and <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Europe</span> by way of strategic acquisitions and organic growth of services to existing patients.</li> </ul> <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">TORONTO</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 5, 2021</span> /CNW/ - Braxia Scientific Corp. (the &#34;Company&#34;), (CSE:<a class="ticker" href="https://www.benzinga.com/stock/BRAX#CSE" rel="nofollow">BRAX</a>) (FWB: 496) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/SHRMF#OTCQB" rel="nofollow">SHRMF</a>), is pleased to announce the rebranding of its growing network of research and treatment clinics to Braxia Health. The Company also provided an update on its plan to expand its research and treatment and clinic footprint to address significant opportunities in the North American multi-billion-dollar mental healthcare market.  Additionally, Braxia Scientific commenced trading under its new ticker &#34;CSE: BRAX&#34;.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1505889/Braxia_Scientific_Corp__Braxia_Scientific_Introduces__Braxia_Hea.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1505889/Braxia_Scientific_Corp__Braxia_Scientific_Introduces__Braxia_Hea.jpg" title="Braxia Scientific Corp. Logo (CNW Group/Braxia ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/21/05/n21021727/braxia-scientific-introduces-braxia-health-a-growing-network-of-clinics-leading-novel-psychedelic- alt=Braxia Scientific Introduces &quot;Braxia Health&quot; a Growing Network of Clinics Leading Novel Psychedelic Research and Treatments for Mental Disorders>Full story available on Benzinga.com</a></p> CSE:BRAX New Products/Services SHRMF Small Cap Press Releases Fri, 07 May 2021 21:30:00 +0000 PRNewswire 21021727 at https://www.benzinga.com Braxia Scientific Introduces "Braxia Health" a Growing Network of Clinics Leading Novel Psychedelic Research and Treatments for Mental Disorders https://www.benzinga.com/pressreleases/21/05/n21021726/braxia-scientific-introduces-braxia-health-a-growing-network-of-clinics-leading-novel-psychedelic- <ul xmlns="http://www.w3.org/1999/xhtml" type="disc"> <li xmlns="http://www.w3.org/1999/xhtml">Braxia Scientific enters a new chapter as it commences trading under its new ticker &#34;CSE: BRAX&#34; and rebrands its growing network of leading clinics to Braxia Health, which includes the Canadian Rapid Treatment Centre of Excellence established in 2018. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Only clinic in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Canada</span> previously involved in a randomized controlled pivotal trial for regulatory approval purposes of psilocybin for the treatment of adults with depression. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Led by Dr. <span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Roger McIntyre</span>, the top-rated expert in <a xmlns="http://www.w3.org/1999/xhtml" target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3152666-2&amp;h=4010939238&amp;u=https%3A%2F%2Fexpertscape.com%2Fgo%2Fdepression&amp;a=depression" rel="nofollow" rel="nofollow">depression</a> since 2010 as rated by Expertscape, Braxia Health has the largest clinical research footprint for ketamine and psychedelic-based research in the world, providing the fastest route to development of its IP capable formulations and IP capable delivery methods. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">First community-based centre in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Canada</span> to specialize in rapid-acting treatments for patients with treatment resistant major depressive disorder and bipolar disorder. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">First <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Ontario</span> based centre licenced by the College of Physicians and Surgeons Ontario under the Out of Hospital Premises Program to perform ketamine IV treatments for depression. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Over 3,000 intravenous Ketamine Infusions and 345 intranasal and sublingual Ketamine treatments administered to date in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Canada</span>. <br xmlns="http://www.w3.org/1999/xhtml" /><br xmlns="http://www.w3.org/1999/xhtml" /></li> <li xmlns="http://www.w3.org/1999/xhtml">Focused on robust expansion throughout <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Canada</span>, the U.S. and <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Europe</span> by way of strategic acquisitions and organic growth of services to existing patients.</li> </ul> <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">TORONTO</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">May 5, 2021</span> /PRNewswire/ - Braxia Scientific Corp. (the &#34;Company&#34;), (CSE:<a class="ticker" href="https://www.benzinga.com/stock/BRAX#CSE" rel="nofollow">BRAX</a>) (FWB: 496) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/SHRMF#OTCQB" rel="nofollow">SHRMF</a>), is pleased to announce the rebranding of its growing network of research and treatment clinics to Braxia Health. The Company also provided an update on its plan to expand its research and treatment and clinic footprint to address significant opportunities in the North American multi-billion-dollar mental healthcare market.  Additionally, Braxia Scientific commenced trading under its new ticker &#34;CSE: BRAX&#34;.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1505889/Braxia_Scientific_Corp__Braxia_Scientific_Introduces__Braxia_Hea.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/21/05/n21021726/braxia-scientific-introduces-braxia-health-a-growing-network-of-clinics-leading-novel-psychedelic- alt=Braxia Scientific Introduces &quot;Braxia Health&quot; a Growing Network of Clinics Leading Novel Psychedelic Research and Treatments for Mental Disorders>Full story available on Benzinga.com</a></p> CSE:BRAX New Products/Services SHRMF Small Cap Press Releases Fri, 07 May 2021 21:30:00 +0000 PRNewswire 21021726 at https://www.benzinga.com Cannabis Stock Gainers And Losers From May 7, 2021 https://www.benzinga.com/markets/cannabis/21/05/21020643/cannabis-stock-gainers-and-losers-from-may-7-2021 <h3>GAINERS:</h3> <ul> <li><strong><a href="https://quotes.benzinga.com/quote/TBPMF" target="_blank">Tetra Bio Pharma</a>&nbsp;</strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/tbpmf#OTC">TBPMF</a>) shares closed up 22.62% at $0.38</li> <li><strong><a href="https://quotes.benzinga.com/quote/IVITF" target="_blank">Invictus MD Strategies</a>&nbsp;</strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/ivitf#OTC">IVITF</a>) shares closed up 16.28% at $0.05</li> <li><strong><a href="https://quotes.benzinga.com/quote/TLRY" target="_blank">Tilray</a>&nbsp;(</strong>NASDAQ:TLRY) shares closed up 14.35% at $16.18</li> <li><strong><a href="https://quotes.benzinga.com/quote/OGI" target="_blank">OrganiGram Holdings</a>&nbsp;</strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ogi#NASDAQ">OGI</a>) shares closed up 12.7% at $2.75</li> <li><strong><a href="https://quotes.benzinga.com/quote/MGCLF" target="_blank">MGC Pharmaceuticals</a>&nbsp;</strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/mgclf#OTC">MGCLF</a>) shares closed up 12.14% at $0.05</li> <li><strong><a href="https://quotes.benzinga.com/quote/ZYNE" target="_blank">Zynerba Pharmaceuticals</a>&nbsp;</strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zyne#NASDAQ">ZYNE</a>) shares closed up 11.97% at $4.49</li> <li><strong><a href="https://quotes.benzinga.com/quote/ZBISF" target="_blank">Zenabis Global</a>&nbsp;</strong>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/zbisf#OTC">ZBISF</a>) shares closed up 9.06% at $0.11</li> <li><strong><a href="https://quotes.benzinga.com/quote/SNDL" target="_blank">Sundial Growers</a>&nbsp;</strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sndl#NASDAQ">SNDL</a>) shares closed up 7.41% at $0.77</li> <li><strong><a href="https://quotes.benzinga.com/quote/VFF" target="_blank">Village Farms Intl</a>&nbsp;</strong>(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vff#NASDAQ">VFF</a>) shares closed up 7.34% at $11.11</li> <li><strong><a href="https://quotes.benzinga.com/quote/HRVSF" ...</strong></li></ul><p><a href=https://www.benzinga.com/markets/cannabis/21/05/21020643/cannabis-stock-gainers-and-losers-from-may-7-2021 alt=Cannabis Stock Gainers And Losers From May 7, 2021>Full story available on Benzinga.com</a></p> ACB BE BMMJ CANN Cannabis cannabis stocks CNGGF CNTMF CNVCF CRBP CRLBF CURR EPWCF GRWG HEXO HRVSF IVITF legal weed stocks M&A marijuana stocks MBII MGCLF OGI Penny Stocks RHNMF SNDL stocks TBPMF TGODF VFF VIVO ZBISF ZYNE Small Cap After-Hours Center Markets VIVO US5895841014 TGODF MBII EPWCF CANN HEXO OGI CRLBF CRBP HRVSF ZYNE ZBISF ACB CNTMF VFF SNDL BE RHNMF GRWG CNVCF IVITF CURR TBPMF BMMJ CNGGF MGCLF M&A Penny Stocks Cannabis Small Cap After-Hours Center Markets Benzinga Fri, 07 May 2021 21:20:36 +0000 Jose Rodrigo Safdiye 21020643 at https://www.benzinga.com